Certified but Concealed: The Trade Secrecy Loophole That Undermines America's Food Safety Assurance System

The Architecture of Opacity

When Americans purchase a packaged food product bearing a third-party safety certification, they are implicitly trusting a chain of verification that extends from the manufacturer's facility through an accredited auditing body and, ostensibly, into public record. That trust, however, rests on a foundation that is far less transparent than most consumers — or policymakers — recognize. Across the food safety certification landscape in the United States, proprietary testing protocols, confidentiality clauses embedded in auditor contracts, and broad interpretations of trade secret protections collectively ensure that the data underpinning safety declarations remains largely inaccessible to independent researchers, regulatory agencies, and the public.

This opacity is not incidental. It is structural. And its consequences for foodborne illness detection, outbreak attribution, and long-term public health policy are substantial.

How Confidentiality Becomes a Shield

Food safety certification in the United States operates through a decentralized system of private third-party auditors, many of which are accredited under voluntary schemes such as the Global Food Safety Initiative (GFSI) benchmarked standards, including Safe Quality Food (SQF) and the British Retail Consortium (BRC) standard. While the Food and Drug Administration retains statutory authority over food safety under the Food Safety Modernization Act (FSMA) of 2011, a significant portion of day-to-day verification is effectively outsourced to these private bodies.

The commercial relationship between auditor and manufacturer is governed by contract, and those contracts routinely contain nondisclosure provisions that prevent auditors from sharing detailed findings — including specific test results, corrective action reports, and hazard analysis data — with anyone outside the immediate commercial relationship. Manufacturers, in turn, invoke trade secret protections under both federal law and a patchwork of state statutes to resist disclosure requests from regulators, researchers, and litigants.

The practical result is that the evidentiary record of food safety testing is fragmented, privately held, and largely unverifiable. An auditor may certify that a facility meets a given standard; what that certification actually measured, how it was measured, and what deviations were recorded and subsequently waived remains opaque.

The Epidemiological Consequences

The inability of independent researchers to access proprietary food safety data creates demonstrable blind spots in outbreak science. When a foodborne illness cluster emerges — whether linked to leafy greens, ready-to-eat deli products, or processed ingredients distributed across complex supply chains — epidemiologists depend on traceback investigations that require access to production records, environmental testing results, and audit histories. The withholding of this information under trade secrecy claims can delay source attribution by weeks or months, during which ongoing exposure continues.

Several high-profile outbreaks over the past decade have illustrated this dynamic. In cases where facilities held current third-party certifications at the time contamination occurred, post-outbreak investigations revealed that audit records contained unresolved findings that had not been escalated to regulators. Because those records were treated as confidential commercial information, neither the FDA nor state health departments had visibility into the warning signals that preceded the outbreak.

Beyond acute outbreak response, the cumulative effect of data inaccessibility on longitudinal food safety research is equally consequential. Epidemiologists studying patterns of contamination across commodity categories, production regions, or supply chain configurations cannot conduct rigorous analyses when the underlying testing data is proprietary. Peer-reviewed research in this domain is constrained not by methodological limitations but by deliberate information architecture.

The Regulatory Gap FSMA Did Not Close

The Food Safety Modernization Act was widely heralded as a transformative shift toward preventive food safety governance. Its preventive controls provisions require manufacturers to conduct hazard analyses and implement control measures, and its supply chain program provisions extend accountability upstream to ingredient suppliers. What FSMA did not do, however, was mandate meaningful public disclosure of the testing data generated under these frameworks.

The FDA retains authority to inspect facilities and review records, but that authority operates within constraints. Confidential commercial information submitted to or collected by the agency is afforded significant protection under the Freedom of Information Act's Exemption 4, which has been interpreted broadly following the Supreme Court's 2019 decision in Food Marketing Institute v. Argus Leader Media. That ruling expanded the scope of information qualifying for trade secret protection, further insulating food safety data from public access.

The consequence is a regulatory architecture in which the government possesses enforcement authority but limited evidentiary transparency, and in which the private certification infrastructure that fills the gap operates under confidentiality norms incompatible with independent verification.

International Comparisons and Reform Pathways

Several peer jurisdictions have adopted more disclosure-oriented approaches to food safety data governance. The European Union's General Food Law Regulation, as amended in 2019 following the European Food Safety Authority's transparency review, introduced provisions requiring greater public access to studies submitted in support of regulatory authorizations, including safety assessments. While imperfect and subject to ongoing implementation debates, the European model reflects a policy judgment that public health verification interests can and must be balanced against commercial confidentiality claims.

In the United States, reform proposals have emerged from academic public health communities and consumer advocacy organizations, though they have not yet achieved legislative traction. Among the most substantive proposals are requirements that third-party auditors operating under FSMA-recognized accreditation schemes report aggregate testing outcomes and corrective action rates to a centralized, publicly accessible registry — without disclosing facility-identifying information that would constitute genuine trade secrets. A second class of proposals would establish a protected research access pathway, modeled loosely on arrangements in pharmaceutical regulation, through which credentialed researchers could access de-identified safety testing data under confidentiality agreements that permit publication of aggregate findings.

Both approaches would require legislative action, either through FSMA amendment or through standalone food safety transparency legislation. Neither has been introduced in the current Congress, reflecting the sustained lobbying influence of food manufacturing trade associations and the absence of a politically mobilized consumer constituency around data access issues.

The Verification Deficit as a Public Health Problem

At its core, the trade secrecy problem in food safety certification is a verification problem. Certification without verifiability is not assurance — it is attestation. And attestation, in the absence of independent corroboration, is structurally insufficient as the evidentiary basis for a public health system that serves more than 330 million Americans consuming food from an increasingly complex and globalized supply chain.

The scholarly and policy communities have an obligation to name this gap clearly. The question is not whether manufacturers have legitimate interests in protecting genuinely proprietary production processes. They do. The question is whether those interests justify a system in which the safety of the food supply cannot be independently verified — and in which that inability is not a technical limitation but a legal design feature.

Reforming that design will require political will, coordinated advocacy, and a regulatory framework willing to distinguish between trade secrets that protect innovation and confidentiality claims that protect opacity. Until that distinction is operationalized in law, Americans will continue to eat under a certification system whose evidence base they are structurally prohibited from examining.